Salvarsan - the first chemotherapeutic compound
dc.contributor.author | Lloyd, Nicholas C. | en_US |
dc.contributor.author | Morgan, Hugh W. | en_US |
dc.contributor.author | Nicholson, Brian K. | en_US |
dc.contributor.author | Ronimus, Ron S. | en_US |
dc.contributor.author | Riethmiller, Steven | en_US |
dc.date.accessioned | 2008-03-19T05:11:26Z | |
dc.date.available | 2007-09-09 | en_US |
dc.date.available | 2008-03-19T05:11:26Z | |
dc.date.issued | 2005-01-01 | en_US |
dc.identifier.citation | Lloyd, N.C., Morgan, H.W., Nicholson, B.K., Ronimus, R.S. & Riethmiller, S. (2005). Salvarsan the first chemotherapeutic compound. Chemistry in New Zealand, 69(1), 24-27 | en_US |
dc.identifier.uri | https://hdl.handle.net/10289/188 | |
dc.format.mimetype | application/pdf | |
dc.language.iso | en | |
dc.publisher | Ancat Holdings Ltd | en_NZ |
dc.relation.uri | http://www.nzic.org.nz/CiNZ/CiNZ.html | en_US |
dc.rights | This is an authors version of an article published in the journal, Chemistry in New Zealand, (c) 2005 New Zealand Institute of Chemistry | en_US |
dc.subject | Salvarsan | en_US |
dc.subject | Ehrlich | en_US |
dc.subject | chemotherapy | en_US |
dc.subject | synthesis | en_US |
dc.title | Salvarsan - the first chemotherapeutic compound | en_US |
dc.type | Journal Article | en_US |
dc.relation.isPartOf | Chemistry in New Zealand | en_NZ |
pubs.begin-page | 24 | en_NZ |
pubs.edition | March | en_NZ |
pubs.elements-id | 30810 | |
pubs.end-page | 27 | en_NZ |
pubs.issue | 1 | en_NZ |
pubs.volume | 69 | en_NZ |